6 completed, 2 withdrawn, 1 recruiting. 9 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 6, Withdrawn 2, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow nalmefene: new trials by email Literature Review of nalmefene trials Research Report on nalmefene
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nalmefene vs Naloxone for the Treatment of Recurrent Respiratory Depression After Opioid Overdose Nalmefene Injection, Naloxone Injection - Opioid Overdose, Opiate Overdose | Phase 3 | Withdrawn | University of New Mexico | 2024-08-26 | 2025-02-10 | |
| NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions Nalmefene, Placebo - Behavioural Addiction | Phase 3 | Recruiting | Nantes University Hospital | 266 | 2023-03-31 | 2025-02-12 |
| Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence. Nalmefene (Selincro®) 18 mg tablet, placebo - Cirrhosis, Alcohol Dependence | Phase 3 | Withdrawn | Centre Hospitalier Universitaire, Amiens | 2018-12-01 | 2023-07-20 | |
| A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence Nalmefene hydrochloride - Alcohol Dependence | Phase 3 | Completed | Otsuka Pharmaceutical Co., Ltd. | 405 | 2015-07-13 | 2020-07-20 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial) Nalmefene hydrochloride, Placebo - Alcohol Dependence | Phase 3 | Completed | Otsuka Pharmaceutical Co., Ltd. | 678 | 2015-02-09 | 2019-09-30 |
| Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence Placebo, Nalmefene - Alcohol Dependence | Phase 3 | Completed | H. Lundbeck A/S | 665 | 2009-03-01 | 2013-08-07 |
| Efficacy of Nalmefene in Patients With Alcohol Dependence Placebo, Nalmefene - Alcohol Dependence | Phase 3 | Completed | H. Lundbeck A/S | 678 | 2009-03-01 | 2013-07-22 |
| Efficacy of Nalmefene in Patients With Alcohol Dependence Placebo, Nalmefene - Alcohol Dependence | Phase 3 | Completed | H. Lundbeck A/S | 598 | 2008-12-01 | 2013-07-09 |
| Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling nalmefene HCl, Placebo - Pathological Gambling | Phase 2 / Phase 3 | Completed | Somaxon Pharmaceuticals | 233 | 2005-08-01 | 2008-05-19 |
Alcoholism (6) · Alcohol-Related Disorders (3) · Mental Disorders (3) · Gambling (2) · Compulsive Sexual Behavior Disorder (1) · Drug Overdose (1) · Fibrosis (1) · Food Addiction (1) · Opiate Overdose (1) · Respiratory Insufficiency (1)
H. Lundbeck A/S (3) · Otsuka Pharmaceutical Co., Ltd. (2) · Centre Hospitalier Universitaire, Amiens (1) · Nantes University Hospital (1) · Somaxon Pharmaceuticals (1) · University of New Mexico (1)
France (3) · Czechia (2) · Japan (2) · Poland (2) · Austria (1) · Belgium (1) · Estonia (1) · Finland (1) · Germany (1) · Hungary (1) · Italy (1) · Latvia (1) · Lithuania (1) · Portugal (1) · Russia (1)
Caitlin Bonney, MD (1) · Osamu Sato (1) · Philip Jochelson, MD (1)
PMID 25227627, PMID 23873853, PMID 25832297, PMID 23237314, PMID 23562264